Bone Marrow Necrosis After Treatment with Sulphasalazine

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1984 Sep 29

PMID 6148120

Citations 5

Authors

J E Van de Pette

D T Cunnah

T M Shallcross

Affiliations

Soon will be listed here.

Citing Articles

Sulfasalazine-induced Pancytopenia Indicating Bone Marrow Suppression: A Rare Pediatric Case Report from Pakistan.

Marsia S, Mahmood S, Raza M, Nusrat K, Saleem A Cureus. 2019; 11(4):e4462.

PMID: 31249740 PMC: 6579356. DOI: 10.7759/cureus.4462.

Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report.

Ek S, Rosenborg S Medicine (Baltimore). 2018; 96(50):e9277.

PMID: 29390381 PMC: 5815793. DOI: 10.1097/MD.0000000000009277.

Sulphasalazine in arthritis--an old drug rediscovered.

Taggart A Clin Rheumatol. 1987; 6(3):378-83.

PMID: 2894913 DOI: 10.1007/BF02206836.

Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.

Capell H, Pullar T, Hunter J Drugs. 1986; 32 Suppl 1:44-8.

PMID: 2877852 DOI: 10.2165/00003495-198600321-00009.

Sulphasalazine associated pancytopenia may be caused by acute folate deficiency.

Logan E, Williamson L, RYRIE D Gut. 1986; 27(7):868-72.

PMID: 2874103 PMC: 1433557. DOI: 10.1136/gut.27.7.868.

References

Jamshidi K, Arlander T, Garcia M, Windschitl H, Swaim W . Azulfidine agranulocytosis with bone marrow, megakaryocytosis, histiocytosis and plasmacytosis. Minn Med. 1972; 55(6):545-8. View

Maddocks J, Slater D . Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine. J R Soc Med. 1980; 73(8):587-8. PMC: 1437808. DOI: 10.1177/014107688007300811. View

Brown 3rd C . Bone marrow necrosis. A study of seventy cases. Johns Hopkins Med J. 1972; 131(3):189-203. View

Koskinen P . Pancytopenia during salazopyrin treatment; a case report. Ann Chir Gynaecol Fenn Suppl. 1954; 43(5):180-3. View